← Back
Data updated: Mar 10, 2026
ZYDUS PHARMS USA
CardiovascularNeurologyInfectious Disease
ZYDUS PHARMS USA is a generic drug manufacturer focused on Cardiovascular, Neurology, Infectious Disease.
2005
Since
67
Drugs
-
Trials
810
Approved (2yr)
Recent Activity
GABAPENTIN 2026-02-24
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
MYCOPHENOLATE MOFETIL 2026-02-23
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 46%
6 drugs
Neurology 23%
3 drugs
Infectious Disease 15%
2 drugs
Gastroenterology 8%
1 drugs
Metabolic 8%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Merck big-pharma
Infectious Disease, Cardiovascular, Metabolic
Novo Nordisk big-pharma
Metabolic, Cardiovascular, Infectious Disease, Neurology
Johnson & Johnson big-pharma
Infectious Disease, Cardiovascular, Metabolic
AZURITY specialty
Cardiovascular, Neurology, Metabolic, Infectious Disease
WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology, Infectious Disease
Active (27)
EDARAVONE CLOFARABINE ZOLMITRIPTAN PIOGLITAZONE HYDROCHLORIDE IRBESARTAN ATOMOXETINE HYDROCHLORIDE ANASTROZOLE LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE TAMSULOSIN HYDROCHLORIDE LEVETIRACETAM DIVALPROEX SODIUM CARVEDILOL VENLAFAXINE HYDROCHLORIDE SIMVASTATIN LAMOTRIGINE PRAVASTATIN SODIUM RAMIPRIL MELOXICAM RIBAVIRIN TOPIRAMATE OMEPRAZOLE AMIODARONE HYDROCHLORIDE RANITIDINE HYDROCHLORIDE AZATHIOPRINE CLINDAMYCIN HYDROCHLORIDE ATENOLOL PROPRANOLOL HYDROCHLORIDE
Discontinued (24)
GABAPENTIN MYCOPHENOLATE MOFETIL AMLODIPINE BESYLATE FINASTERIDE LOSARTAN POTASSIUM TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN HALOPERIDOL METFORMIN HYDROCHLORIDE RISPERIDONE LETROZOLE NAPROXEN PAROXETINE HYDROCHLORIDE PRAMIPEXOLE DIHYDROCHLORIDE WARFARIN SODIUM CINACALCET HYDROCHLORIDE PROMETHAZINE HYDROCHLORIDE HYDROXYCHLOROQUINE SULFATE DONEPEZIL HYDROCHLORIDE GALANTAMINE HYDROBROMIDE DIPYRIDAMOLE DESLORATADINE BENZONATATE BROMOCRIPTINE MESYLATE GLIPIZIDE AND METFORMIN HYDROCHLORIDE
Company Info
- First Approval
- 2005-01-28
- Latest
- 2025-12-23
- Applications
- 81
FDA Sponsor Names
ZYDUS PHARMS USAZYDUS PHARMS USA INC